Longevity Bioscience Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Longevity Bioscience General Information

Description

Provider of plant-based exosome services based in Siena, Italy. The company offers exosome isolation, characterization, engineering, and custom production.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Piazza dell'Abbadia 4
  • 53100 Siena
  • Italy
+39 349
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Corporate Office
  • Piazza dell'Abbadia 4
  • 53100 Siena
  • Italy
+39 349

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longevity Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Longevity Bioscience‘s full profile, request access.

Request a free trial

Longevity Bioscience Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Longevity Bioscience‘s full profile, request access.

Request a free trial

Longevity Bioscience FAQs

  • When was Longevity Bioscience founded?

    Longevity Bioscience was founded in 2024.

  • Where is Longevity Bioscience headquartered?

    Longevity Bioscience is headquartered in Siena, Italy.

  • What industry is Longevity Bioscience in?

    Longevity Bioscience’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Longevity Bioscience a private or public company?

    Longevity Bioscience is a Private company.

  • What is the current valuation of Longevity Bioscience?

    The current valuation of Longevity Bioscience is .

  • What is Longevity Bioscience’s current revenue?

    The current revenue for Longevity Bioscience is .

  • Who are Longevity Bioscience’s investors?

    Arterra Bioscience has invested in Longevity Bioscience.

  • When was Longevity Bioscience acquired?

    Longevity Bioscience was acquired on 31-Jul-2025.

  • Who acquired Longevity Bioscience?

    Longevity Bioscience was acquired by Exosomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process